Tempus AI, Inc. has entered into an Agreement and Plan of Merger with Personalis, Inc., involving two merger steps with its subsidiaries, resulting in Personalis becoming a wholly-owned subsidiary of Tempus.

US · 2026-07-20

1. Step 1 · The triggerTempus AI announces acquisition of Personalis, combining AI platform with MRD testing.
2. Step 2 · Knock-onCombined entity gains scale and cross-selling opportunities, intensifying competition in precision oncology.
3. Step 3 · Reaches youRivals (Natera, Guardant Health, Exact Sciences) face pressure to differentiate or consolidate, potentially triggering M&A or pricing shifts.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: SEC EDGAR — Current filings

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.